- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, October 7, 2022
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article by Becker's Payer Issues covered a study published in the October 2022 issue of The American Journal of Managed Care® (AJMC®). In the study, “Turnover Among New Medicare Advantage Enrollees May Be Greater Than Perceived,” findings revealed that enrollees who join Medicare Advantage undergo significant turnover in the years following enrollment.
Another study published in the AJMC® October issue, “The Impact of HDHPs on Service Use and Spending for Substance Use Disorders,” was referenced by MedCity News. The study showed that offering a high-deductible health plan (HDHP) led to a 6.6% reduction in the probability of using substance use disorder services and a shift in spending from the plan to the enrollee.
A piece by Health Digest cited an article published on AJMC.com, the website of AJMC®. The article, “Chemotherapy Demand Will Rise Significantly by 2040, and Workforce Will Need to Expand With It,” indicated that the number of patients requiring first-line chemotherapy is expected to increase by more than 50% from 2018 to 2040.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
